摘要:
A method is provided for producing ammonia (NH3) and introducing the produced ammonia (NH3) into an exhaust gas stream as a reduction means for selectively catalytically reducing nitrogen oxides contained in the exhaust gas stream, which is an exhaust stream generated by the combustion process of a motor, a gas turbine, or a burner. The method comprises feeding dry urea from a supply container in a controlled amount to reactor and subjecting the dry urea in the reactor to a sufficiently rapid thermal treatment such that a gas mixture comprising the reaction products of ammonia (NH3) and isocyanic acid (HCNO) is created. Also, the method comprises immediately catalytically treating the thus produced gas mixture in the presence of water such that the isocyanic acid (HCNO) resulting from the rapid thermal treatment is converted, via quantitative hydrolysis treatment, into ammonia (NH3) and carbon dioxide (CO2).
摘要:
A device for coupling and decoupling two shafts or other elements of a drive train for transmitting rotations or torques especially to be used as a clutch segment in the field of motorcycle drives is provided. The clutch segment includes two parts one of which comprise troughs or recesses being arranged on a circle and offset by essentially the same angle. The troughs are at least approximately tangentially abutting an inner circle. The troughs linearly extend from their deepest point, beginning with a radius of the inner circle, at an angle towards an edge thereof and turn over towards the edge of a radius. A force application point for applying a force for coupling or decoupling the elements is located at a distance from a rotation axis of the clutch segment.
摘要:
The present invention relates to 1-aza-bicycloalkyl derivatives of Formula (I); wherein the substituents are as defined in the specification, to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them. Formula (I), wherein A represents O or N(R1); Y represents a group of formula, or wherein the left bond is attached to the A group and the right bond is attached to the R group; R represents a substituted or unsubstituted C5-C10aryl, substituted or unsubstituted hetero-C5-C10aryl, a group N(R1)(R4), or a group N(R2)(CHP3R4); R represent a hydrogen, C1-C4alkyl, or CF3; R2 represents hydrogen, C1-C4alkyl, or CF3; R3 represents hydrogen, C1-C4alkyl, or CF3; R4 represents a substituted or unsubstituted C5-C10 aryl or a substituted or unsubstituted C5-C10heteroaryl; in free base or acid addition salt form.
摘要:
The present invention relates to a polypeptide having interleukin-10 function, comprising two interleukin-10 monomer subunits covalently linked by a linker. The present invention further relates to a nucleic acid molecule encoding the polypeptide of the invention, a vector comprising said nucleic acid molecule, a non-human host transformed with the nucleic acid molecule or the vector of the invention as well as a method for the production of a recombinant polypeptide of the invention. The present invention further relates to a pharmaceutical composition as well as to the polypeptide, the nucleic acid molecule, the vector or the host or host cell of the invention for use in treating and/or preventing inflammatory diseases.
摘要:
The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
摘要翻译:本申请涉及包含200-1000U / mL [等摩尔至200-1000IU人胰岛素]甘精胰岛素的水性药物制剂。
摘要:
The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
摘要翻译:本申请涉及包含200-1000U / mL [等摩尔至200-1000IU人胰岛素]甘精胰岛素的水性药物制剂。
摘要:
The present invention relates to 1-aza-bicycloalkyl derivatives of Formula (I); wherein the substituents are as defined in the specification, to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them. Formula (I), wherein A represents O or N(R1); Y represents a group of formula, or wherein the left bond is attached to the A group and the right bond is attached to the R group; R represents a substituted or unsubstituted C5-C10aryl, substituted or unsubstituted hetero-C5-C10aryl, a group N(R1)(R4), or a group N(R2)(CHP3R4); R represent a hydrogen, C1-C4alkyl, or CF3; R2 represents hydrogen, C1-C4alkyl, or CF3; R3 represents hydrogen, C1-C4alkyl, or CF3; R4 represents a substituted or unsubstituted C5-C10 aryl or a substituted or unsubstituted C5-C10heteroaryl; in free base or acid addition salt form.
摘要:
Use of a protein of the SDF-1-family for the manufacturing of a medicament for the improvement of the plasticity and/or regeneration of axons upon their lesion.
摘要:
The present invention relates to the use of recombinant silicatein-β or silicatein-β isolated from natural sources as well as to silicatein-β-fusion proteins as well as silicatein-β-related enzymes for the synthesis, the degradation and for modification of silicon dioxide (condensation products of silicic acid, silicates), silicones and other silicon(IV)- or metal(IV)-compounds, and their technical uses.
摘要:
What is described here is a method of manufacturing spectacles comprising individual progressive ophthalmic lenses, including the following steps: selection of a spectacle frame, detection of the shape of the lens rings with a precision better than ±0.5 mm in the x- and y-directions (data set 1), detecting the intersection points of the lines of sight through the plane of the lens rings for at least two design distances of the progressive ophthalmic lenses with a precision better than ±1 mm (data set 2) selection and positioning relative to the lens rings of a spherical or non-spherical surface in view of the prescription data, using the data sets 1 and 2 (data set 3), computing and positioning the progressive surface relative to the selected surface, with minimization of the critical thickness of the ophthalmic lens, using the data sets 1 to 3 (data set 4), manufacturing the progressive surfaces as well as edges of the ophthalmic lenses from a non-edged semi-finished product finished on one side, using the data sets 1 to 4.